206 related articles for article (PubMed ID: 90473)
1. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification.
Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A
Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473
[TBL] [Abstract][Full Text] [Related]
2. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections.
Sourek J
Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type.
Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F
J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704
[TBL] [Abstract][Full Text] [Related]
4. Serological classification of Pseudomonas aeruginosa by a slide agglutination test.
Kusama H
J Clin Microbiol; 1978 Aug; 8(2):181-8. PubMed ID: 100507
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes].
Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES
Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445
[TBL] [Abstract][Full Text] [Related]
6. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
Joó I; Stanislavsky ES; Zhvanetskaya MI; Mashilova GM; Gladus MA
Acta Microbiol Acad Sci Hung; 1982; 29(4):267-75. PubMed ID: 6821018
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine].
Schiller B; Lysakowska E; Owczarska K
Med Dosw Mikrobiol; 1981; 33(2):91-6. PubMed ID: 6170849
[No Abstract] [Full Text] [Related]
8. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein.
Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES
Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393
[TBL] [Abstract][Full Text] [Related]
9. Serological typing of Pseudomonas aeruginosa--comparison of various antigenic schema.
Homma JY; Hirao Y; Saku K; Terada Y; Sugiyama JI
Jpn J Exp Med; 1977 Jun; 47(3):195-201. PubMed ID: 72174
[TBL] [Abstract][Full Text] [Related]
10. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
[TBL] [Abstract][Full Text] [Related]
11. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection.
Okada K; Kawaharajo K; Kasai T; Homma JY
Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131
[TBL] [Abstract][Full Text] [Related]
12. Pseudomonas aeruginosa antigens as potential vaccines.
Stanislavsky ES; Lam JS
FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
[TBL] [Abstract][Full Text] [Related]
13. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey).
Joó I; Stanislavskii ES
J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316
[TBL] [Abstract][Full Text] [Related]
14. Mouse-protection experience with monovalent Pseudomonas aeruginosa vaccine.
Sourek J; Výmola F; Zelenková L
Zentralbl Bakteriol A; 1980 Mar; 246(3):353-62. PubMed ID: 6775443
[TBL] [Abstract][Full Text] [Related]
15. [Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens].
Stanislavskiĭ ES; Zhvanetskaia MI; Mashilova GM; Gladus MA
Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):66-72. PubMed ID: 6778035
[TBL] [Abstract][Full Text] [Related]
16. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
17. Antigenic changes in Pseudomonas aeruginosa in vivo and after lysogenization in vitro.
Lányi B; Lantos J
Acta Microbiol Acad Sci Hung; 1976; 23(4):337-51. PubMed ID: 829016
[TBL] [Abstract][Full Text] [Related]
18. A new polyvalent pseudomonas vaccine.
Merle P; Robbel L; Hungerer KD
Behring Inst Mitt; 1984 Nov; (76):113-20. PubMed ID: 6441560
[TBL] [Abstract][Full Text] [Related]
19. Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa.
Saha S; Takeshita F; Sasaki S; Matsuda T; Tanaka T; Tozuka M; Takase K; Matsumoto T; Okuda K; Ishii N; Yamaguchi K; Klinman DM; Xin KQ; Okuda K
Vaccine; 2006 Sep; 24(37-39):6240-9. PubMed ID: 16806598
[TBL] [Abstract][Full Text] [Related]
20. Immunological study of Pseudomonas aeruginosa extracellular slime.
Stanislavsky ES; Yushkova NA; Edvabnaya LS; Landsman NM; Zaidner IG
Acta Microbiol Hung; 1985; 32(1):49-59. PubMed ID: 2412390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
